Lipid oxidation inactivates the anticoagulant function of protein Z-dependent protease inhibitor (ZPI)

J Biol Chem. 2017 Sep 1;292(35):14625-14635. doi: 10.1074/jbc.M117.793901. Epub 2017 Jul 17.

Abstract

Lipid oxidation due to oxidative stress plays an important role in the pathogenesis of inflammatory and thrombotic cardiovascular diseases. Several findings suggest that lipid peroxidation can alter the function of coagulation proteins and contribute to a hypercoagulable state, but the molecular mechanisms are unclear. Here, we report that oxidized phospholipids suppress the anticoagulant function of the serpin, protein Z-dependent protease inhibitor (ZPI), a specific inhibitor of membrane-associated factor Xa (FXa) that requires protein Z (PZ), phospholipid, and calcium as cofactors. We found that this suppression arises from a diminished ability of the oxidized membrane to function as a cofactor to promote ZPI inhibition of membrane-bound FXa, due fully or in part to the susceptibility of the bound ZPI-PZ complex to oxidative inactivation. Surprisingly, free ZPI was also susceptible to inactivation by oxidized membrane vesicles in the absence of calcium. Oxidized vesicles containing both phosphatidylserine and polyunsaturated fatty acids were required to promote inactivation of the ZPI-PZ complex or free ZPI, indicating that binding of the PZ-complexed or free ZPI to peroxide-modified phospholipid vesicles mediates the inactivation. Heparin protected the ZPI-PZ complex and free ZPI from inactivation, suggesting that blocking the heparin-binding site on ZPI interferes with ZPI binding to lipid or to PZ. This was confirmed by direct lipid-binding experiments. Native PAGE indicated that oxidization induced dissociation of the ZPI-PZ complex and increased the negative charge of ZPI. We conclude that compromised ZPI anticoagulant function could contribute to thrombus initiation and growth in oxidative stress-induced cardiovascular diseases.

Keywords: coagulation factor; lipid oxidation; protease inhibitor; serpin; thrombosis.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Anticoagulants / chemistry
  • Anticoagulants / metabolism
  • Anticoagulants / pharmacology
  • Binding Sites
  • Binding, Competitive
  • Blood Coagulation* / drug effects
  • Blood Proteins / agonists
  • Blood Proteins / chemistry
  • Blood Proteins / metabolism*
  • Calcium Signaling
  • Factor Xa / chemistry
  • Factor Xa / metabolism*
  • Heparin / chemistry
  • Heparin / metabolism
  • Heparin / pharmacology
  • Humans
  • Kinetics
  • Lipid Bilayers / chemistry
  • Lipid Bilayers / metabolism*
  • Lipid Peroxidation*
  • Models, Biological*
  • Oxidative Stress / drug effects
  • Phosphatidylcholines / chemistry
  • Phosphatidylcholines / metabolism
  • Phosphatidylserines / chemistry
  • Phosphatidylserines / metabolism
  • Protein Multimerization / drug effects
  • Recombinant Proteins / chemistry
  • Recombinant Proteins / metabolism
  • Serpins / agonists
  • Serpins / chemistry
  • Serpins / genetics
  • Serpins / metabolism*
  • Surface Properties

Substances

  • Anticoagulants
  • Blood Proteins
  • Lipid Bilayers
  • Phosphatidylcholines
  • Phosphatidylserines
  • Recombinant Proteins
  • SERPINA10 protein, human
  • Serpins
  • plasma protein Z
  • 1,2-dioleoylphosphatidylserine
  • Heparin
  • Factor Xa